A new study has discovered a link between triglycerides and obstructive sleep apnea (“OSA”). Triglycerides are a type of lipid in the blood that gives energy to an individual’s body. High triglyceride levels raise an individual’s risk of pancreatitis, strokes and heart attack.
On the other hand, obstructive sleep apnea is a sleep disorder that causes an individual’s airway to close while they sleep, which prevents the lungs from oxygenating the blood sufficiently. This common sleep disorder has many symptoms, which include choking, gasping, loud snoring, drowsiness, morning headaches, poor school and job performance, hyperactivity in young children and waking up repeatedly throughout the night.
The research, which was conducted by researchers at the Freemason’s Centre for Male Health and Wellbeing, was led by Gary Wittert, a professor of medicine at the University of Adelaide.
The study found that participants with decreases in blood oxygen concentrations and severe obstructive sleep apnea had a higher chance of having elevated triglyceride concentrations in their blood. Wittert, who is also the director of the Freemason’s centre, stated that obstructive sleep apnea heightened an individual’s risk of developing depression, cardiovascular conditions, stroke and type 2 diabetes.
For their study, the researchers recruited participants from the Men Androgens Inflammation Lifestyle Environment and Stress Study (MAILES). The study assesses the health of men aged 40 and above in Australia. The researchers found that more than one-half of their recruits had moderate to severe obstructive sleep apnea, noting that 75% of them had some form of the condition.
Wittert explained that the research’s results were concerning as the most distinct effects of the conditions were observed in individuals who weren’t overweight. He added that while the sleep condition also affected lean individuals and was pretty common, it was rarely recognized until a person’s health was seriously undermined. The professor noted that the main takeaway from this research was that testing for obstructive sleep apnea needed to be considered, particularly in lean men who had high triglyceride concentrations.
The scientists recommend the use of continuous positive airway pressure therapy, which is delivered through a machine overnight, as it may help reduce obstructive sleep apnea symptoms as well as triglyceride concentrations. Wittert does assert that more research is needed to assess the relationship between triglycerides and obstructive sleep apnea in young men and women, as well as to evaluate the effectiveness of CPAP treatment for every age group.
With many companies making highly effective treatments for OSA, patients have viable options to keep the condition under control and avoid the complications that result when obstructive sleep apnea isn’t treated.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
